{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T05:21:15Z","timestamp":1769923275871,"version":"3.49.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.mcna.2008.03.007","type":"journal-article","created":{"date-parts":[[2008,6,19]],"date-time":"2008-06-19T08:33:49Z","timestamp":1213864429000},"page":"813-837","source":"Crossref","is-referenced-by-count":33,"title":["The Hepatorenal Syndrome"],"prefix":"10.1016","volume":"92","author":[{"given":"Santiago J.","family":"Munoz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2008.03.007_bib1","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.cgh.2007.04.027","article-title":"Nationwide increase in hospitalizations and hepatitis C among inpatients with cirrhosis and sequelae of portal hypertension","volume":"5","author":"Nguyen","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.mcna.2008.03.007_bib2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites","volume":"105","author":"Gines","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mcna.2008.03.007_bib3","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis","volume":"133","author":"Fernandez","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mcna.2008.03.007_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2003.50016","article-title":"Model for end-stage liver disease (MELD) and allocation of donor livers","volume":"124","author":"Wiesner","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mcna.2008.03.007_bib6","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.20083","article-title":"MELD score as a predictor of pretransplant and posttransplant survival in OPTN\/UNOS status 1 patients","volume":"39","author":"Kremers","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2008.03.007_bib7","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cgh.2006.08.007","article-title":"Natural history of patients hospitalized for management of cirrhotic ascites","volume":"4","author":"Planas","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.mcna.2008.03.007_bib8","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/00042737-199909000-00004","article-title":"Renal failure in acute liver failure","volume":"11","author":"Moore","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.mcna.2008.03.007_bib9","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s10620-006-9099-z","article-title":"Prevalence of septic events, type 1 hepatorenal syndrome, and mortality in severe alcoholic hepatitis and utility of discriminant function and MELD score in predicting these adverse events","volume":"51","author":"Verma","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.mcna.2008.03.007_bib10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2008.03.007_bib11","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jhep.2007.02.001","article-title":"Advances in the pathogenesis and treatment of type 1 and type-2 hepatorenal syndrome","volume":"46","author":"Arroyo","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.mcna.2008.03.007_bib12","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2008.03.007_bib13","first-page":"501A","article-title":"Renal dysfunction following liver transplantation: a comparison of novel renal biomarkers in the post transplant period","volume":"46","author":"Portal","year":"2007","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.mcna.2008.03.007_bib14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1872-034X.2007.00086.x","article-title":"Novel approaches to assessing renal function in cirrhotic liver disease","volume":"37","author":"Portal","year":"2007","journal-title":"Hepatol Res"},{"key":"10.1016\/j.mcna.2008.03.007_bib15","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","article-title":"MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation","volume":"41","author":"Alessandria","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2008.03.007_bib16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.7326\/0003-4819-144-10-200605160-00007","article-title":"Brief communication: glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation","volume":"144","author":"McGuire","year":"2006","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2008.03.007_bib17","first-page":"474A","article-title":"High prevalence of glomerulonephritis in patients with end-stage HCV-induced cirrhosis","volume":"46","author":"McGuire","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2008.03.007_bib18","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/hep.20066","article-title":"AASLD Practice Guideline: management of adult patients with refractory ascites","volume":"39","author":"Runyon","year":"2004","journal-title":"Hepatology"},{"issue":"4 Suppl 1","key":"10.1016\/j.mcna.2008.03.007_bib19","first-page":"543A","article-title":"Retrospective analysis of 140 patients labeled as hepatorenal syndrome in a referral center","volume":"42","author":"Servin-Abad","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2008.03.007_bib20","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1111\/j.1572-0241.2002.05920.x","article-title":"Hepatorenal syndrome: diagnostic accuracy, clinical features and outcome in a tertiary care center","volume":"97","author":"Watt","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mcna.2008.03.007_bib21","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1111\/j.1572-0241.2005.00271.x","article-title":"Treatment of hepatorenal syndrome as defined by the international ascites club by albumin and furosemide infusion according to the central venous pressure: a prospective pilot study","volume":"100","author":"P\u00e9ron","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mcna.2008.03.007_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hep.20262","article-title":"Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome","volume":"40","author":"Wong","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2008.03.007_bib23","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2002.34343","article-title":"Effects of noradrenaline and albumin in patients with type 1 hepatorenal syndrome: a pilot study","volume":"36","author":"Duvoux","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2008.03.007_bib24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/hep.1840060216","article-title":"Hepatorenal syndrome without avid sodium retention","volume":"6","author":"Dudley","year":"1986","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2008.03.007_bib25","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2215\/CJN.01340406","article-title":"Hepatorenal syndrome: pathophysiology and management","volume":"1","author":"Wadei","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.mcna.2008.03.007_bib26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","author":"Ruiz-del-Arbol","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2008.03.007_bib27","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1053\/jhep.2003.50447","article-title":"Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis","volume":"38","author":"Ruiz-del-Arbol","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2008.03.007_bib28","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0002-9343(70)80074-2","article-title":"Plasma renin in hepatic cirrhosis: relation to functional renal failure","volume":"49","author":"Schroeder","year":"1970","journal-title":"Am J Med"},{"key":"10.1016\/j.mcna.2008.03.007_bib29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2362.1983.tb00100.x","article-title":"Sympathetic nervous activity, renin-angiotensin system and renal excretion of prostaglandin-E2 in cirrhosis: relationship to functional renal failure, and sodium and water excretion","volume":"13","author":"Arroyo","year":"1983","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.mcna.2008.03.007_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0168-8278(86)80154-4","article-title":"Urinary excretion of 6-keto prostaglandin F1-alpha, thromboxane B-2 and prostaglandin E2 in cirrhosis with ascites: relationship to functional renal failure (hepatorenal syndrome)","volume":"3","author":"Rimola","year":"1986","journal-title":"J Hepatol"},{"key":"10.1016\/j.mcna.2008.03.007_bib31","first-page":"59","article-title":"Effect of dipyridamole on kidney function in cirrhosis","volume":"17","author":"Llach","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2008.03.007_bib32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/hep.20832","article-title":"Hepatorenal syndrome: is it central hypovolemia, a cardiac disease, or part of gradually developing multiorgan dysfunction?","volume":"42","author":"Lenz","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2008.03.007_bib33","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/hep.21101","article-title":"Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock","volume":"43","author":"Tsai","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2008.03.007_bib34","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/hep.21352","article-title":"Adrenal insufficiency in patients with cirrhosis and septic shock: effect of treatment with hydrocortisone on survival","volume":"44","author":"Fernandez","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2008.03.007_bib35","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/hep.20373","article-title":"Effects of contrast media on renal function in patients with cirrhosis: a prospective study","volume":"40","author":"Guevara","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2008.03.007_bib36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/hep.21443","article-title":"Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features","volume":"45","author":"Fasolato","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2008.03.007_bib37","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1053\/j.gastro.2005.09.024","article-title":"Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score","volume":"129","author":"Terra","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mcna.2008.03.007_bib38","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.21907","article-title":"Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis","volume":"46","author":"Garcia-Tsao","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2008.03.007_bib39","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1111\/j.1572-0241.2000.03214.x","article-title":"Hepatorenal syndrome in cirrhotic patients: terlipressine is a safe and efficient treatment; propranolol and digitalic treatments: precipitating and preventing factors?","volume":"95","author":"Duhamel","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mcna.2008.03.007_bib40","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1053\/jhep.2003.50133","article-title":"Hemodynamic response to pharmacological treatment of portal hypertension and long term prognosis of cirrhosis","volume":"37","author":"Abraldes","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2008.03.007_bib41","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1055\/s-2006-947293","article-title":"New treatments of hepatorenal syndrome","volume":"26","author":"Arroyo","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.mcna.2008.03.007_bib42","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/hep.21094","article-title":"The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond","volume":"43","author":"Moreau","year":"2006","journal-title":"Hepatology"},{"issue":"30","key":"10.1016\/j.mcna.2008.03.007_bib43","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.3748\/wjg.v13.i30.4046","article-title":"Hepatorenal syndrome","volume":"13","author":"Turban","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2008.03.007_bib44","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S0168-8278(03)00007-2","article-title":"Ascites and hepatorenal syndrome in ascites: pathophysiological basis of therapy and current management","volume":"38","author":"Arroyo","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.mcna.2008.03.007_bib45","first-page":"1","article-title":"Hepatorenal syndrome: a dreaded complication of end-stage liver disease","volume":"100","author":"C\u00e1rdenas","year":"2005","journal-title":"Am J\u00a0Gastroenterol"},{"key":"10.1016\/j.mcna.2008.03.007_bib46","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMra035021","article-title":"Management of cirrhosis and ascites","volume":"350","author":"Gin\u00e8s","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2008.03.007_bib47","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/00042737-200212000-00013","article-title":"Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2","volume":"14","author":"Alessandria","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.mcna.2008.03.007_bib48","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1365-2036.2006.03086.x","article-title":"Meta-analysis: terlipressine therapy for the hepatorenal syndrome","volume":"24","author":"Fabrizi","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mcna.2008.03.007_bib49","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0168-8278(05)80042-X","article-title":"Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure","volume":"17","author":"Gines","year":"1993","journal-title":"J Hepatol"},{"key":"10.1016\/j.mcna.2008.03.007_bib50","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide","volume":"29","author":"Angeli","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2008.03.007_bib51","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0140-6736(96)91667-0","article-title":"Amelioration of hepatorenal syndrome with selective endotheline-A antagonist","volume":"347","author":"Soper","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2008.03.007_bib52","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(05)74933-3","article-title":"Improvement in renal function in hepatorenal syndrome with N-acetylcysteine","volume":"353","author":"Holt","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2008.03.007_bib53","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hep.21940","article-title":"Lack of renal improvement with nonselective endothelin antagonism with tezosentan in type 2 hepatorenal syndrome","volume":"47","author":"Wong","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2008.03.007_bib54","first-page":"CD005162","article-title":"Terlipressin for hepatorenal syndrome","volume":"4","author":"Gluud","year":"2006","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.mcna.2008.03.007_bib55","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1365-2036.2007.03303.x","article-title":"Systematic review: renal and other clinically relevant outcomes in hepatorenal syndrome trials","volume":"25","author":"Tandon","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mcna.2008.03.007_bib56","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","article-title":"Noradrenaline vs terlipressin in patients with hepatorenal syndrome: a prospective randomized unblinded pilot study","volume":"47","author":"Alessandria","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.mcna.2008.03.007_bib57","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2003.09.019","article-title":"Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome: a case-control study","volume":"40","author":"Restuccia","year":"2004","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2008.03.007_bib58","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/S0168-8278(07)61680-8","article-title":"Randomized comparative study of terlipressin and albumin vs albumin alone in patients with cirrhosis and hepatorenal syndrome","volume":"46","author":"Martin-Llahi","year":"2007","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2008.03.007_bib59","first-page":"449A","article-title":"Noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome: a randomized controlled trial","volume":"44","author":"Sharma","year":"2006","journal-title":"Hepatology"},{"issue":"4 Suppl 1","key":"10.1016\/j.mcna.2008.03.007_bib60","first-page":"694A","article-title":"A prospective randomized double blind placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"44","author":"Sanyal","year":"2006","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2008.03.007_bib61","first-page":"564A","article-title":"Prognostic factors for hepatorenal syndrome (HRS) reversal in patients with type 1 HRS enrolled in a randomized double blind placebo controlled trial","volume":"46","author":"Sanyal","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2008.03.007_bib62","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0168-8278(98)80151-7","article-title":"Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome","volume":"29","author":"Hadengue","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.mcna.2008.03.007_bib63","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(00)80158-0","article-title":"Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome","volume":"33","author":"Uriz","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.mcna.2008.03.007_bib64","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/gast.2002.32364","article-title":"Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study","volume":"122","author":"Moreau","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mcna.2008.03.007_bib65","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, non-randomized study","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2008.03.007_bib66","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00042737-200202000-00009","article-title":"Effects of terlipressin (glypressin) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study","volume":"14","author":"Halimi","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.mcna.2008.03.007_bib67","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1440-1746.2002.02816.x","article-title":"Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with terlipressin: a retrospective analysis","volume":"17","author":"Colle","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.mcna.2008.03.007_bib68","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1440-1746.2003.02934.x","article-title":"Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial","volume":"18","author":"Solanki","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.mcna.2008.03.007_bib69","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s10620-006-9312-0","article-title":"Octreotide\/midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome","volume":"52","author":"Estrailian","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.mcna.2008.03.007_bib70","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/hep.510280407","article-title":"Acute effects of oral administration of midodrine, an alpha adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites","volume":"28","author":"Angeli","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2008.03.007_bib71","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.47.2.288","article-title":"Long-term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study","volume":"47","author":"Brensing","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.mcna.2008.03.007_bib72","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/hep.510280219","article-title":"Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems","volume":"28","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2008.03.007_bib73","first-page":"1753","article-title":"Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation","volume":"50","author":"Testino","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.mcna.2008.03.007_bib74","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jhep.2005.06.005","article-title":"A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites","volume":"43","author":"Albillos","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.mcna.2008.03.007_bib75","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1053\/j.gastro.2005.07.031","article-title":"Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis","volume":"129","author":"D'Amico","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mcna.2008.03.007_bib76","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1053\/j.gastro.2007.06.020","article-title":"Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data","volume":"133","author":"Salerno","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mcna.2008.03.007_bib77","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/hep.20044","article-title":"Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy","volume":"39","author":"Shawcross","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2008.03.007_bib78","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jhep.2007.04.015","article-title":"Comparison of terlipressin and noradrenalin on cerebral perfusion, intracranial pressure and cerebral extracellular concentrations of lactate and pyruvate in patients with acute liver failure in need of inotropic support","volume":"47","author":"Eefsen","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.mcna.2008.03.007_bib79","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00003246-199303000-00007","article-title":"Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure","volume":"21","author":"Davenport","year":"1993","journal-title":"Crit Care Med"},{"key":"10.1016\/j.mcna.2008.03.007_bib80","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/01.sla.0000124298.74199.e5","article-title":"Prospective randomized multicenter controlled trial of a bioartificial liver in treating acute liver failure","volume":"239","author":"Demetriou","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.mcna.2008.03.007_bib81","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/lv.2000.6355","article-title":"Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of prospective, randomized, controlled clinical trial","volume":"6","author":"Mitzner","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1016\/j.mcna.2008.03.007_bib82","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000086552","article-title":"The Prometheus device for extracorporeal support of combined liver and renal failure","volume":"23","author":"Rifai","year":"2005","journal-title":"Blood Purif"},{"issue":"4 Suppl 1","key":"10.1016\/j.mcna.2008.03.007_bib83","first-page":"695A","article-title":"A new liver support device: first results of a phase I clinical trial in patients with acute-on-chronic liver failure","volume":"44","author":"Munoz","year":"2006","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.mcna.2008.03.007_bib84","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1744-9987.2007.00505.x","article-title":"A case report of hepatorenal syndrome treated with plasma diafiltration (selective plasma filtration with dialysis)","volume":"11","author":"Nakae","year":"2007","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.mcna.2008.03.007_bib85","series-title":"Ascites and renal dysfunction in liver disease","first-page":"271","article-title":"Liver transplantation for patients with cirrhosis and ascites","author":"Rimola","year":"2005"},{"key":"10.1016\/j.mcna.2008.03.007_bib86","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00007890-199102000-00030","article-title":"Long term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome: experience in 300 patients","volume":"51","author":"Gonwa","year":"1991","journal-title":"Transplantation"},{"key":"10.1016\/j.mcna.2008.03.007_bib87","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00007890-199502150-00010","article-title":"Impact of pretransplant renal function on survival after liver transplantation","volume":"59","author":"Gonwa","year":"1995","journal-title":"Transplantation"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2008.03.007_bib88","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1016\/j.jhep.2004.12.007","article-title":"Management of complications of cirrhosis in patients awaiting liver transplantation","volume":"42","author":"C\u00e1rdenas","year":"2005","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.mcna.2008.03.007_bib89","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archsurg.141.8.735","article-title":"Long term analysis of combined liver and kidney transplantation at a single center","volume":"141","author":"Ruiz","year":"2006","journal-title":"Arch Surg"},{"issue":"6","key":"10.1016\/j.mcna.2008.03.007_bib90","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/lt.21149","article-title":"Hepatorenal syndrome: a proposal for kidney after liver transplantation (KALT)","volume":"13","author":"Ruiz","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.mcna.2008.03.007_bib91","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1600-6143.2007.01856.x","article-title":"Simultaneous liver-kidney transplantation: evaluation to decision making","volume":"7","author":"Davis","year":"2007","journal-title":"Am J Transpl"},{"key":"10.1016\/j.mcna.2008.03.007_bib92","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"5","author":"Sort","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2008.03.007_bib93","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mcna.2008.03.007_bib94","first-page":"249A","article-title":"Pentoxifylline for the treatment of patients with advanced cirrhosis: a randomized placebo-controlled double blind trial","volume":"46","author":"Lebrec","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2008.03.007_bib95","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jhep.2007.08.004","article-title":"Pharmacological treatment of hepatorenal syndrome: a note of optimism","volume":"47","author":"Salerno","year":"2007","journal-title":"J Hepatol"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712508000278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712508000278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T19:57:22Z","timestamp":1545940642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712508000278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":94,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0025712508000278"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2008.03.007","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}